FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38735711000001106: Yargesa 100mg capsules (Piramal Critical Care Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1498551000001117 Yargesa 100mg capsules (Piramal Critical Care Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1498561000001119 Yargesa 100mg capsules (Piramal Critical Care Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Is a Product containing precisely miglustat 100 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Is a Yargesa true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has specific active ingredient Miglustat true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has AMP True Yargesa 100mg capsules (Piramal Critical Care Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start